Joseph A Odin, MD, PhD
- PROFESSOR | Medicine, Liver Diseases
Dr. Odin is a Professor in the Department of Medicine and the Recanati/Miller Transplantation Institute with a clinical background in gastroenterology and liver disease. He is co-director of the Mount Sinai Autoimmune Liver Disease Programs. He has research interest in liver autoimmunity and drug induced liver injury. His current research studies are focused on primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, and evaluation of drug hepatotoxicity. He cares for individuals with all liver diseases including those with liver transplants. His research is supported by the NIH and he has received past support and awards from the American Gastroenterological Association and the American Association for the Study of Liver Disease. He also receives support from pharmaceutical companies for participation in clinical treatment trials for liver diseases.
Dr. Odin is an inaugural Fellow of the American Association for the Study of Liver Diseases (FAASLD) — the highest honor among AASLD membership categories — which recognizes superior professional achievement in clinical or academic practice, and in basic or clinical research.
RMTI Website: www.MountSinaiRMTI.org
Autoimmune Liver Disease Treatment Program
- Endoscopic Band Ligation
- Esophageal Varices
- Hepatitis A
- Hepatitis B
AB, Cornell University
MD, Mount Sinai Sch. of Medicine CUNY
Residency, Internal Medicine, The Mount Sinai Hospital
Fellowship, Gastroenterology, Johns Hopkins Hospital
Solomon Silver Award for Clinical Research
Research Excellence in GI and Liver Disease Award
Dr. Odin's liver research focuses on Autoimmune Liver Disease, Toxicity, Fatty Liver Disease, and Viral Hepatitis. Clinical trials and studies are being conducted or planned for primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, drug or toxin induced liver injury, hepatitis B and C, and non-alcoholic fatty liver disease. Some of the research is investigator initiated while other studies are supported by the National Institutes of Health or Pharmaceutical Companies. Please go to Programs in Autoimmune Liver Diseases.